Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC

NCT06603402 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma (ESCC)
Immunotherapy

Interventions

RADIATION: low-dose involved-field radiotherapy combined with immunochemotherapy

Sponsor

Sichuan University